Clinical Pharmacokinetics of Intra-arterial Melphalan and Topotecan Combination in Patients with Retinoblastoma
- 1 April 2014
- journal article
- Published by Elsevier in Ophthalmology
- Vol. 121 (4) , 889-897
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Retinoblastoma frontiers with intravenous, intra-arterial, periocular, and intravitreal chemotherapyEye, 2012
- Three-drug intra-arterial chemotherapy using simultaneous carboplatin, topotecan and melphalan for intraocular retinoblastoma: preliminary resultsBritish Journal of Ophthalmology, 2012
- Pharmacokinetic Analysis of Melphalan after Superselective Ophthalmic Artery Infusion in Preclinical Models and Retinoblastoma PatientsInvestigative Ophthalmology & Visual Science, 2012
- Efficacy and Complications of Super-selective Intra-ophthalmic Artery Melphalan for the Treatment of Refractory RetinoblastomaOphthalmology, 2012
- Intra-arterial Chemotherapy for RetinoblastomaArchives of Ophthalmology (1950), 2011
- Selective Ophthalmic Arterial Injection Therapy for Intraocular Retinoblastoma: The Long-Term PrognosisOphthalmology, 2011
- Intra-arterial Chemotherapy for the Management of RetinoblastomaArchives of Ophthalmology (1950), 2011
- Bilateral Superselective Ophthalmic Artery Chemotherapy for Bilateral Retinoblastoma: Tandem TherapyArchives of Ophthalmology (1950), 2010
- A Phase I/II Study of Direct Intraarterial (Ophthalmic Artery) Chemotherapy with Melphalan for Intraocular RetinoblastomaOphthalmology, 2008
- Phase I study of topotecan in combination with cyclophosphamide in pediatric patients with malignant solid tumors: a Pediatric Oncology Group Study.Journal of Clinical Oncology, 1998